{
  "id": "insilico-s-ai-obesity-drug-hits-up-to-31-3-weight-loss",
  "title": "Insilico’s AI obesity drug hits up to 31.3% weight loss",
  "summary": "Preclinical results spotlight a new AI-driven approach to obesity, one tied less to appetite alone and more to long-term metabolic health. It is hard to miss how fast obesity drugs have moved from specialist clinics to dinner-table conversations, especially this year, when more and more weight-loss drugs are going mainstream. GLP-1 therapies reshaped expectations almost […] The post Insilico’s AI obesity drug hits up to 31.3% weight loss appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/insilicos-ai-obesity-drug-hits-up-to-31-3-weight-loss/",
  "source": "Longevity.Technology",
  "author": "Kyle Umipig",
  "category": "news",
  "publishedAt": "2026-02-02T17:00:38.000Z",
  "fetchedAt": "2026-02-04T10:49:05.816Z",
  "relevanceScore": 0.2,
  "matchedKeywords": [
    "longevity"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.887Z"
}